Stacey Gibson

Stacey Gibson is an experienced National Patient Access Liaison currently working in the Rare Disease Business Unit at Amgen since October 2023, and previously held a similar position at Horizon focused on infused medicines, earning the 2022 President’s Club recognition. Gibson has held key roles in market access and reimbursement at SUN PHARMA, Eli Lilly and Company, and Amerisource Bergen, specializing in complex Oncology markets and patient access solutions. Early career experience includes coordinating financial and scheduling issues for hematology and transplant services at the Cancer Institute of New Jersey. Gibson holds a Master of Science in Health Care Administration from Rutgers University and a Bachelor of Science in Business Management from Bloomfield College.